Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Buy
2,417
+13
+0.5% +$2.69K 0.01% 963
2026
Q1
$540K Sell
2,404
-77
-3% -$19.2K 0.01% 852
2025
Q4
$598K Sell
2,481
-91
-4% -$23.3K 0.01% 792
2025
Q3
$682K Sell
2,572
-169
-6% -$46.2K 0.02% 713
2025
Q2
$754K Buy
2,741
+146
+6% +$34.8K 0.02% 614
2025
Q1
$612K Buy
2,595
+1,719
+196% +$401K 0.02% 627
2024
Q4
$208K Buy
+876
New +$211K 0.01% 1014
2024
Q2
Sell
-1,182
Closed -$234K 1147
2024
Q1
$234K Buy
+1,182
New +$217K 0.01% 975

Other funds holding RMD

Mutual Advisors's RMD Position: Q2 2026 in Review

Mutual Advisors increased its ResMed (RMD) stake by 0.54% in Q2 2026, buying an estimated $2.69K and bringing the position to 2,417 shares worth $471K. The position accounts for 0.01% of the portfolio, ranked #963.

Mutual Advisors first reported a position in RMD in Q1 2024 and has held it in 8 quarters since. The position peaked at $754K in Q2 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Mutual Advisors held 2,417 shares of ResMed worth $471K as of Q2 2026.
  • Mutual Advisors bought 13 ResMed shares in Q2 2026, an estimated $2.69K.
  • ResMed made up 0.01% of Mutual Advisors's portfolio in Q2 2026, its #963 holding.
  • Mutual Advisors first reported a position in ResMed in Q1 2024 and has held it in 8 quarters since.
  • Mutual Advisors's ResMed position peaked at $754K in Q2 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Mutual Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.